Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-041987

Director bought 262 shares at an average $3.29 ($862)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2025-08-01 Purchase 10b5-1 +13 $3.44 $45 43,689 D
Jones James Director 2025-08-04 Purchase 10b5-1 +13 $4.01 $52 43,702 D
Jones James Director 2025-08-05 Purchase 10b5-1 +13 $3.92 $51 43,715 D
Jones James Director 2025-08-06 Purchase 10b5-1 +13 $3.34 $43 43,728 D
Jones James Director 2025-08-07 Purchase 10b5-1 +13 $3.14 $41 43,741 D
Jones James Director 2025-08-08 Purchase 10b5-1 +13 $3.39 $44 43,754 D
Jones James Director 2025-08-11 Purchase 10b5-1 +13 $2.87 $37 43,767 D
Jones James Director 2025-08-12 Purchase 10b5-1 +13 $2.91 $38 43,780 D
Jones James Director 2025-08-13 Purchase 10b5-1 +13 $2.94 $38 43,793 D
Jones James Director 2025-08-14 Purchase 10b5-1 +13 $2.84 $37 43,806 D
Jones James Director 2025-08-15 Purchase 10b5-1 +13 $3.02 $39 43,819 D
Jones James Director 2025-08-18 Purchase 10b5-1 +13 $3.11 $40 43,832 D
Jones James Director 2025-08-19 Purchase 10b5-1 +13 $3.23 $42 43,845 D
Jones James Director 2025-08-20 Purchase 10b5-1 +2 $3.15 $6 43,847 D
Jones James Director 2025-08-21 Purchase 10b5-1 +13 $3.25 $42 43,860 D
Jones James Director 2025-08-22 Purchase 10b5-1 +13 $3.31 $43 43,873 D
Jones James Director 2025-08-25 Purchase 10b5-1 +13 $3.32 $43 43,886 D
Jones James Director 2025-08-26 Purchase 10b5-1 +13 $3.39 $44 43,899 D
Jones James Director 2025-08-27 Purchase 10b5-1 +13 $3.44 $45 43,912 D
Jones James Director 2025-08-28 Purchase 10b5-1 +13 $3.47 $45 43,925 D
Jones James Director 2025-08-29 Purchase 10b5-1 +13 $3.45 $45 43,938 D
Open-market purchases · 262 sh · avg $3.29 · $862
Loading xslF345X05/wk-form4_1757680522.xml…